Justin Virgin – Executive Director – Terrain Minerals (ASX:TMX) is a West Australian based minerals exploration company focused on the world class mineral provinces in Western Australia. Terrain is actively looking for opportunities within other states of Australia and internationally.
Copyright 2024 – Finance News Network
Source: Finance News Network
13 Sep 2024 - Control Bionics Limited (ASX:CBL) CEO Jeremy Steele provides an overview of the company, discussing its suite of augmentative and alternative communication products.
Read More29 Jan 2021 - Cyclopharm (ASX:CYC) CEO & Managing Director, James McBrayer talks about its recent cap raising to support rapid USA commercialisation for Technegas following USFDA approval targeted in Q2 2021.
Read More21 Mar 2021 - Elixinol Global (ASX:EXL) CEO, Oliver Horn talks about its proposed acquisition of CannaCare Health GmbH (CannaCare) one of Germany’s leading CBD (Cannabidiol) brands following the down scheduling of CBD in Europe late last year in what the Company sees as highly strategic opportunity and important pathway to profitability.
Read More14 Dec 2021 - icetana Limited (ASX:ICE) CEO and Managing Director Matt Macfarlane discusses the company's $2.7m share placement, as well as recent deals with NEC and Panasonic.
Read More28 Nov 2022 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses the LAG-3 landscape, the company's portfolio of therapies, encouraging data from the 2022 SITC conference and the outlook for 2023.
Read More29 Aug 2025 - Expanding technology and market reach
Read More27 Feb 2024 - QX Resources Limited (ASX:QXR) Managing Director Steve Promnitz discusses iron ore results from the company's assets in the Pilbara.
Read More30 Jul 2024 - Andrew Penkethman - CEO & Managing Director - Ardea Resources (ASX:ARL) is an ASX-listed nickel resources company, with a large portfolio of 100%-controlled West Australian-based projects.
Read More03 Dec 2019 - Noxopharm Limited (ASX:NOX) Executive Chairman & CEO, Dr Graham Kelly, discusses clinical results from the company's Phase 1b clinical DARRT-1 trial for its lead product candidate, Veyonda, with low-dose radiotherapy.
Read More16 Aug 2023 - Yoav Amitai - CEO - Elsight's (ASX:ELS) Halo provides connectivity and delivers absolute connection confidence for drones and other unmanned systems.
Read More
